Human lymphoid tissues harbor a distinct CD69+CXCR6+ NK cell population

Journal of Immunology

Volumn 197, Issue 1, 2016, Pages 78-84

  Lugthart, Gertjan ^a   Melsen, Janine E ^a   Vervat, Carly ^a   Van Ostaijen Ten Dam, Monique M ^a   Corver, Willem E ^a   Roelen, Dave L ^a   Van Bergen, Jeroen ^a   Van Tol, Maarten J D ^a   Lankester, Arjan C ^a   Schilham, Marco W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR6; DNAX ACCESSORY MOLECULE 1; GAMMA INTERFERON; GRANZYME B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 7 RECEPTOR ALPHA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PERFORIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; CD226 ANTIGEN; CHEMOKINE RECEPTOR; CXCR6 PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; NCR1 PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN; VIRUS RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BONE MARROW; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; CELL CULTURE; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; METABOLISM;

ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS;

EID: 84975217629     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502603     Document Type: Article

References (50)

1. Krebs, P., M. J. Barnes, K. Lampe, K. Whitley, K. S. Bahjat, B. Beutler, E. Janssen, and K. Hoebe. 2009. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood 113: 6593-6602.
2. Scharton, T. M., and P. Scott. 1993. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178: 567-577.
3. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
4. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5: 1260-1265.
5. Askenase, M. H., S. J. Han, A. L. Byrd, D. Morais da Fonseca, N. Bouladoux, C. Wilhelm, J. E. Konkel, T. W. Hand, N. Lacerda-Queiroz, X. Z. Su, et al. 2015. Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection. Immunity 42: 1130-1142.
6. Pak-Wittel, M. A., L. Yang, D. K. Sojka, J. G. Rivenbark, and W. M. Yokoyama. 2013. Interferon-g mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc. Natl. Acad. Sci. USA 110: E50-E59.
7. Crome, S. Q., P. A. Lang, K. S. Lang, and P. S. Ohashi. 2013. Natural killer cells regulate diverse T cell responses. Trends Immunol. 34: 342-349.
8. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
9. Montaldo, E., G. Del Zotto, M. Della Chiesa, M. C. Mingari, A. Moretta, A. De Maria, and L. Moretta. 2013. Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. Cytometry A 83: 702-713.
10. Romagnani, C., K. Juelke, M. Falco, B. Morandi, A. D'Agostino, R. Costa, G. Ratto, G. Forte, P. Carrega, G. Lui, et al. 2007. CD56brightCD162 killer Iglike receptor2 NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178: 4947-4955.
11. Béziat, V., D. Duffy, S. N. Quoc, M. Le Garff-Tavernier, J. Decocq, B. Combadière, P. Debré, and V. Vieillard. 2011. CD56brightCD16+ NK cells: A functional intermediate stage of NK cell differentiation. J. Immunol. 186: 6753-6761.
12. Matos, M. E., G. S. Schnier, M. S. Beecher, L. K. Ashman, D. E. William, and M. A. Caligiuri. 1993. Expression of a functional c-kit receptor on a subset of natural killer cells. J. Exp. Med. 178: 1079-1084.
13. Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
14. Fauriat, C., E. O. Long, H. G. Ljunggren, and Y. T. Bryceson. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115: 2167-2176.
15. De Maria, A., F. Bozzano, C. Cantoni, and L. Moretta. 2011. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc. Natl. Acad. Sci. USA 108: 728-732.
16. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
17. Westermann, J., and R. Pabst. 1992. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Investig. 70: 539-544.
18. Fehniger, T. A., M. A. Cooper, G. J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M. A. Caligiuri. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
19. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Munz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
20. Tomasello, E., N. Yessaad, E. Gregoire, K. Hudspeth, C. Luci, D. Mavilio, J. Hardwigsen, and E. Vivier. 2012. Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues. Front. Immunol. 3: 344.
21. Eissens, D. N., J. Spanholtz, A. van der Meer, B. van Cranenbroek, H. Dolstra, J. Kwekkeboom, F. W. Preijers, and I. Joosten. 2012. Defining early human NK cell developmental stages in primary and secondary lymphoid tissues. PLoS One 7: e30930.
22. Carrega, P., I. Bonaccorsi, E. Di Carlo, B. Morandi, P. Paul, V. Rizzello, G. Cipollone, G. Navarra, M. C. Mingari, L. Moretta, and G. Ferlazzo. 2014. CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. J. Immunol. 192: 3805-3815.
23. Grégoire, C., L. Chasson, C. Luci, E. Tomasello, F. Geissmann, E. Vivier, and T. Walzer. 2007. The trafficking of natural killer cells. Immunol. Rev. 220: 169-182.
24. Freud, A. G., J. Yu, and M. A. Caligiuri. 2014. Human natural killer cell development in secondary lymphoid tissues. Semin. Immunol. 26: 132-137.
25. Hazenberg, M. D., and H. Spits. 2014. Human innate lymphoid cells. Blood 124: 700-709.
26. Lugthart, G., M. M. van Ostaijen-ten Dam, M. J. van Tol, A. C. Lankester, and M. W. Schilham. 2015. CD56(dim)CD162 NK cell phenotype can be induced by cryopreservation. Blood 125: 1842-1843.
27. Heemskerk, B., T. van Vreeswijk, L. A. Veltrop-Duits, C. C. Sombroek, K. Franken, R. M. Verhoosel, P. S. Hiemstra, D. van Leeuwen, M. E. Ressing, R. E. Toes, et al. 2006. Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J. Immunol. 177: 8851-8859.
28. Pahl, J. H., S. E. Ruslan, E. P. Buddingh, S. J. Santos, K. Szuhai, M. Serra, H. Gelderblom, P. C. Hogendoorn, R. M. Egeler, M. W. Schilham, and A. C. Lankester. 2012. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma. Clin. Cancer Res. 18: 432-441.
29. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, et al. 2003. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
30. Marquardt, N., V. Béziat, S. Nyström, J. Hengst, M. A. Ivarsson, E. Kekäläinen, H. Johansson, J. Mjösberg, M. Westgren, T. O. Lankisch, et al. 2015. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J. Immunol. 194: 2467-2471.
31. Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Munz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.
32. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
33. Jacobs, R., M. Stoll, G. Stratmann, R. Leo, H. Link, and R. E. Schmidt. 1992. CD162 CD56+ natural killer cells after bone marrow transplantation. Blood 79: 3239-3244.
34. Cosulich, M. E., A. Rubartelli, A. Risso, F. Cozzolino, and A. Bargellesi. 1987. Functional characterization of an antigen involved in an early step of T-cell activation. Proc. Natl. Acad. Sci. USA 84: 4205-4209.
35. Hara, T., L. K. Jung, J. M. Bjorndahl, and S. M. Fu. 1986. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J. Exp. Med. 164: 1988-2005.
36. López-Cabrera, M., A. G. Santis, E. Fernández-Ruiz, R. Blacher, F. Esch, P. Sánchez-Mateos, and F. Sánchez-Madrid. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178: 537-547.
37. Cyster, J. G., and S. R. Schwab. 2012. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30: 69-94.
38. Shiow, L. R., D. B. Rosen, N. Brdicková, Y. Xu, J. An, L. L. Lanier, J. G. Cyster, and M. Matloubian. 2006. CD69 acts downstream of interferonalpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
39. Geissmann, F., T. O. Cameron, S. Sidobre, N. Manlongat, M. Kronenberg, M. J. Briskin, M. L. Dustin, and D. R. Littman. 2005. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3: e113.
40. Palendira, U., R. Chinn, W. Raza, K. Piper, G. Pratt, L. Machado, A. Bell, N. Khan, A. D. Hislop, R. Steyn, et al. 2008. Selective accumulation of virusspecific CD8+ T cells with unique homing phenotype within the human bone marrow. Blood 112: 3293-3302.
41. Hudspeth, K., M. Donadon, M. Cimino, E. Pontarini, P. Tentorio, M. Preti, M. Hong, A. Bertoletti, S. Bicciato, P. Invernizzi, et al. 2016. Human liverresident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J. Autoimmun. 66: 40-50.
42. Peng, H., X. Jiang, Y. Chen, D. K. Sojka, H. Wei, X. Gao, R. Sun, W. M. Yokoyama, and Z. Tian. 2013. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 123: 1444-1456.
43. Paust, S., H. S. Gill, B. Z. Wang, M. P. Flynn, E. A. Moseman, B. Senman, M. Szczepanik, A. Telenti, P. W. Askenase, R. W. Compans, and U. H. von Andrian. 2010. Critical role for the chemokine receptor CXCR6 in NK cellmediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11: 1127-1135.
44. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581.
45. Enqvist, M., E. H. Ask, E. Forslund, M. Carlsten, G. Abrahamsen, V. Béziat, S. Andersson, M. Schaffer, A. Spurkland, Y. Bryceson, et al. 2015. Coordinated expression of DNAM-1 and LFA-1 in educated NK cells. J. Immunol. 194: 4518-4527.
46. Martinet, L., L. Ferrari De Andrade, C. Guillerey, J. S. Lee, J. Liu, F. Souza-Fonseca-Guimaraes, D. S. Hutchinson, T. B. Kolesnik, S. E. Nicholson, N. D. Huntington, and M. J. Smyth. 2015. DNAM-1 expression marks an alternative program of NK cell maturation. Cell Reports 11: 85-97.
47. Zhang, Z., N. Wu, Y. Lu, D. Davidson, M. Colonna, and A. Veillette. 2015. DNAM-1 controls NK cell activation via an ITT-like motif. J. Exp. Med. 212: 2165-2182.
48. Carlsten, M., B. C. Baumann, M. Simonsson, M. Jädersten, A. M. Forsblom, C. Hammarstedt, Y. T. Bryceson, H. G. Ljunggren, E. Hellström-Lindberg, and K. J. Malmberg. 2010. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome. Leukemia 24: 1607-1616.
49. Vossen, M. T., M. Matmati, K. M. Hertoghs, P. A. Baars, M. R. Gent, G. Leclercq, J. Hamann, T. W. Kuijpers, and R. A. van Lier. 2008. CD27 defines phenotypically and functionally different human NK cell subsets. J. Immunol. 180: 3739-3745.
50. Serafini, N., C. A. Vosshenrich, and J. P. Di Santo. 2015. Transcriptional regulation of innate lymphoid cell fate. Nat. Rev. Immunol. 15: 415-428.